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Summary
OBJECTIVE: Therapeutic hypothermia has become a
standard neuroprotective treatment in term newborn infants
following perinatal asphyxia. Active cooling with whole
body surface or head cooling is complex, expensive and
often associated with initial hypothermic overshoot.
We speculated that passive cooling might suffice to induce
and maintain hypothermia.
METHODS: We analysed 18 asphyxiated term newborns
treated with hypothermia in three tertiary neonatal and pae-
diatric intensive care units. Target temperatures of 33.5 °C
or 33.0 °C were induced and maintained by turning off the
heating system of the open neonatal care unit and by us-
ing analgesics and sedatives. We compared our results with
matching published data from the hypothermia trial of the
National Institute of Child Health and Human Develop-
ment (NICHD) neonatal research network.
RESULTS: Four infants required no active cooling at all
during the whole cooling period. The other 14 infants had
passive cooling during 85% of the total cooling time, and
active cooling with ice packs in 15% of the total cooling
time. Overshoot was smaller in the present study than in the
NICHD study.
CONCLUSION: Passive cooling for asphyxiated newborns
appears to be feasible for induction and maintenance of hy-
pothermia with a lower risk of overshoot.
Key words: asphyxia, induced hypothermia, newborn
infant, passive cooling
Introduction
Therapeutic hypothermia has become the standard neuro-
protective treatment modality for term newborns suffering
from encephalopathy following perinatal asphyxia. All
published randomised controlled studies in newborns have
documented its long-term neurological benefit [1–6]. The
technique of hypothermia induction and maintenance re-
mains a subject of research. So far, all clinical studies in
neonates have used active induction of hypothermia either
by head cooling [2] or by total body surface cooling [1,
3–6]. However, the risk of hypothermic overshoot after
initiation of active cooling has been well recognized in
these studies. Uncontrolled and deeper hypothermia has
been shown to accentuate hypothermia-induced side effects
such as pulmonary hypertension, low cardiac output, dys-
rhythmia, coagulopathy, electrolyte disturbances, and
sepsis [7]. Finally, it has been shown in experimental stud-
ies that severe over-cooling may abolish any neuroprotect-
ive effects of therapeutic hypothermia [8].
Cooling is a strong stimulator of thermal stress response
not only in adults, but also in newborns [9]. Thermal stress
response is mainly characterised by peripheral vasocon-
striction and increase in metabolic rate, and it carries the
risk of complete abolishment of the neuroprotective effect
of hypothermia if not controlled [10]. Pharmacological
agents such as sedatives and analgesics have been shown
to decrease stress response by decreasing the endogenous
thermal set point and therefore body temperature [7]. In ad-
dition, human newborns, like other mammalian newborns,
react with an endogenous neuroprotective response to
severe hypoxia, which is characterised by hypothermia and
a reduced metabolic rate [11–12]. In previous experimental
studies, we noticed that postischaemic neonatal rats were
extremely prone to uncontrolled hypothermia in ambient
temperatures [13–14]. We therefore speculated that in situ-
ations of hypothermia induced endogenously by neonatal
hypoxia, further suppression of the thermal set point by
pharmacological agents might suffice not only to quickly
induce but also to maintain hypothermia over a prolonged
period of time. Such a technique may be feasible without
the need of cooling devices.
Three multidisciplinary neonatal and paediatric intensive
care units in Switzerland agreed upon a common standard
treatment protocol based on passive cooling throughout the
necessary period of hypothermia on the one hand, and,
on the other hand, to decrease body temperature with the
aid of pharmacological agents or with ice packs as backup
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cooling methods. In the present report, we summarise pre-
liminary data on the feasibility and safety of passive cool-
ing for induction and maintenance of therapeutic hypother-
mia in asphyxiated infants. In addition, we compare our
results of passive cooling with the results of active cool-
ing from published and successful studies conducted by
the National Institute of Child Health and Human Develop-
ment (NICHD) neonatal research network [3, 15].
Methods
Subjects
We retrospectively collected and analysed data on all as-
phyxiated newborns treated with therapeutic hypothermia
in the neonatal and paediatric intensive care units of
Zurich, Luzern and Bern between 1 April 2005 and 30
June 2007. All babies were treated according to a common
standard protocol similar to the ones used by Eicher et al.
[1] and by Shankaran et al. [3]. The institutional medical
ethics committees approved the study; the requirement for
informed consent was waived.
The inclusion criteria were: A) clinical signs of hypoxia-
ischaemia: severe acidosis (pH ≤7 or BE ≥ –12 mmol/l) at
or within one hour after birth, or a perinatal event (uter-
ine rupture, placental abruption, cord prolapse or rupture,
late or variable decelerations, haemorrhage, cardiorespirat-
ory arrest) combined either with Apgar scores at 5 or 10
minutes of ≤5 or with continuing need of assisted ventil-
ation for more than 5 min after birth and: B) neurologic
signs and symptoms of encephalopathy, i.e., the presence of
postnatal seizures or clinical signs of encephalopathy cor-
responding to Sarnat stages 2 and 3. Exclusion criteria were
inability to start hypothermia treatment within 6 hours after
birth, gestational age <35 weeks, birth weight <2000 g, or
severe congenital malformations.
Cooling technique
Rectal temperature targets were chosen to be above 35 °C
during initial resuscitation and transportation and, follow-
ing admission to the intensive care unit, to be lowered to
33.0 ± 0.5 °C [1] or to 33.5 ± 0.5 °C [3]. The temperature
target was to be reached within two hours of starting cool-
ing. Rectal and toe temperatures were monitored continu-
ously. Passive cooling was achieved by placing the un-
covered infant in a primarily unheated neonatal open care
unit. Room temperature of the intensive care units in
Switzerland are maintained around 24 °C. In addition,
pharmacological agents (barbiturates, opiates or benzo-
diazepines) were given not only to treat discomfort but also
when core temperatures remained above target range des-
pite passive cooling. When pharmacological agents did not
suffice to reach target temperature, or if pharmacologic-
al agents were felt to be contraindicated by the intensivist
in charge, active cooling with ice packs (put on head and
groin) was added. Finally, as a last resort, a cooling mat-
tress could be used. If core temperatures fell below target
range, then the overhead heater from the open care unit was
turned on as needed. After 72 hours of hypothermia, tem-
perature was allowed to increase slowly by 0.5 °C per hour
and kept at 36 ± 0.5 °C for another 48 hours. Breathing gas
temperatures were kept normothermic at all times.
Infants received standard intensive care including extens-
ive laboratory investigations, neurophysiological monitor-
ing, and brain imaging. Arterial blood gases were corrected
for body temperature. Physiological data were documented
hourly. The start of hypothermia was defined as the first
documented core temperature of ≤35°C. Criteria for cessa-
tion of therapeutic hypothermia were intracranial haemor-
rhage, or therapy-refractory shock or pulmonary hyperten-
sion.
Comparison with NICHD studies
For comparison of feasibility and safety of our new passive
cooling protocol we used the data published in the suc-
cessful NICHD studies [3, 15] and searched for matching
data from the newborn group treated with the total body
active cooling protocol. From both groups – our passively
cooled group and the actively cooled NICHD-group – we
compared time from birth to target temperature, incidence
and degree of initial hypothermic overshoot, and variability
of temperature during maintenance cooling. We also com-
pared available data on perinatal characteristics, severity of
illness or adverse events, and short term outcome.
Statistical analysis
Data are presented as mean ± standard deviation, if not
otherwise stated. Normal distribution of data was checked.
When comparing data between the presented study and
the NICHD study, either one-sample or two-sample t-tests
were used or the Fisher’s exact test with the aid of StatXact
9.0 (Cytel Inc, Cambridge, MA, U.S.A).





Birthweight (g) 3136 ± 404 3385 ± 617 p = 0.10&
Gestational age (weeks) 39.4 (±1.5) not documented
Born elsewhere (%) 14 (78) 48 (47) p = 0.021*
Emergency Caesarean section (%) 10 (56) 72 (71) p = 0.27*
pH ≤7.0 or BE ≥ –12 mmol/l 16 (89) not documented
Apgar score ≤5 at 5 min (%) 15 (83) 92 (91) p = 0.41*
Apgar score ≤5 at 10 min (%) 14 (78) 80 (84) p = 1.00*
Time to spontaneous respiration ≥10 min 14 (78) 69 (71) p = 0.58*
Mean ± SD; &Two-sample t-test; *Fisher’s exact test
Original article Swiss Med Wkly. 2013;143:w13767
Swiss Medical Weekly · PDF of the online version · www.smw.ch Page 2 of 6
Results
Study group and perinatal characteristics
A total of 23 infants were treated with therapeutic hypo-
thermia. Five newborns were excluded from data analysis
because of protocol violations: two because the target tem-
perature was chosen to be 34 °C, one because the hypox-
ic insult occurred two hours after birth, and two because
cooling blankets were used from start. Overall, 72% of the
18 remaining newborns had defined perinatal events. At
the start of the therapeutic hypothermia, 6 patients showed
moderate encephalopathy (Sarnat 2), 2 babies had severe
encephalopathy (Sarnat 3), and in 10 infants Sarnat stage
was assumed to be at least moderate. Three infants presen-
ted with clinical seizures. Other perinatal characteristics of
our patients were similar to those of the cooled NICHD
study patients, except for a higher percentage of outborn in-
fants in our study (table 1).
Cooling characteristics
Average temperature changes of the whole cohort during
cooling and rewarming are shown in figure 1. Additional
cooling characteristics are shown in table 2. When com-
pared to the NICHD study, infants in the present study were
cooled and reached target temperature significantly earlier,
whereas the time from initiation of cooling to reaching tar-
get temperature was similar. Maximal overshoot during the
cooling induction was significantly less than in the NICHD
study. The standard deviations of the two average mainten-
Figure 1
Mean rectal temperature (± SD) of the cohort during induction and
maintenance of passive cooling and during rewarming.
ance temperatures during cooling were similar when com-
pared with the NICHD study. In the present study, four
patients (22%) did not require any active cooling at all.
The other 14 newborns (78%) were actively cooled with
ice packs over a total of 9.6 ± 7.5 hours on average, cor-
responding to only 15 ± 10% of total cooling time be-
ing roughly 3.5 days (see fig. 1). Details on active cool-
ing times were missing from one patient. However, cooling
blankets were not used in any of the 18 study patients. All
babies received opiates, and 39% of them were treated with
additional sedatives.
Severity of illness
In the present study, two newborns required no mechanical
ventilation despite cooling and opiates. Seventeen (95%)
of all babies had some form of circulatory support. There
was no proven blood-stream infection, but empiric antibiot-
ic treatment was started in 14 patients. Finally, cooling was
stopped prematurely in six patients. In one infant, this was
done because of cardiac arrhythmias and hyperkalaemia
(potassium concentration of 7.2 mmol/l), which was easily
treated with calcium administration. In another five pa-
tients, cooling was stopped prematurely because of redir-
ection of care and withdrawal of life-sustaining therapy.
Death occurred in six babies during the hospital course. Di-
verse markers of severity of illness were similar when com-
pared with the cooled NICHD study patients, except for a
higher percentage of patients needing cardiovascular drugs
in our study (table 3).
Discussion
In summary, our study showed that passive cooling without
any additional cooling device was feasible for the entire
treatment period in 4 out of 18 newborns suffering from en-
cephalopathy after perinatal insult and in 14 newborns act-
ive cooling with ice packs was applied only during 15%
of total cooling time. This is the first study demonstrating
feasibility of passive cooling during 72 hours for therapeut-
ic hypothermia. Spontaneous hypothermia in newborns has
been known to occur for some time. Newborns suffering
from perinatal asphyxia are especially likely to drop their
body temperature after birth [16]. This phenomenon is part
of an endogenous neuroprotective reaction also found in
other mammalian newborns, and is characterised by hy-
pothermia and hypometabolism [11–12]. In previous ex-
perimental studies with neonatal rats, we could confirm
the occurrence of spontaneous postischaemic hypothermia





Postnatal age at start of cooling (min) 242 ± 103 302 p = 0.024+
Postnatal age when reaching target temperature (min) 319 ± 135 392 p = 0.035+
Induction time from cooling initiation to target temperature (min) 71 ± 53 90 p = 0.15+
Maintenance temperature during cooling at target temperature
At temperature target of 33.5 ± 0.5 °C
At temperature target of 33.0 ± 0.5 °C
33.4 ± 0.6
33.1 ± 0.5 33.4 + 0.9 p = 1.00&
Maximal overshoot during induction in °C –0.4 + 0.6 –1.4 ± 0.6 p <0.001&
Infants (%) with temperatures recorded <32.0 °C after reaching target
temperature
3 (17%) 27 (27%) p = 0.56*
Mean ± SD; +One sample t-test; &Two-sample t-test; *Fisher’s exact test
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[13–14]. All these observations suggest that spontaneous
hypothermia in postischaemic human babies may be suf-
ficient to fulfil the requirements of therapeutic hypother-
mia. Indeed, feasibility of passive cooling during neonatal
transportation has recently been described [17]. In conclu-
sion, postischaemic passive cooling is based upon a solid
physiological background and, as illustrated by the results
of our study, appears to be clinically feasible over 72 hours.
We speculate that with increasing experience the percent-
age of active cooling time will further decrease.
To control overshooting of hypothermia, the overhead heat-
ing device of the open care unit was used. Two other pub-
lished successful RCT’s of postischaemic hypothermia also
used overhead heating devices [2, 6]. This counter-warm-
ing of some parts while cooling centrally or other parts of
the body has been shown in adults to diminish the ther-
moregulatory stress response to hypothermia (shivering
and vasoconstriction) independently from pharmacological
interventions [18]. This is important since an uncontrolled
thermoregulatory stress response may abolish the neuro-
protective properties of hypothermia [10]. Therefore
counter-warming has the potential to enhance the neuro-
protective effects of cooling and appears to be an attractive
adjunct to hypothermia protocols.
Compared with the cooled NICHD study patients [3], there
was an earlier postnatal age at the start of cooling and earli-
er postnatal age when reaching target temperatures in our
study. In experimental studies, time to initiation of cool-
ing and time to reach target temperature have been shown
to be crucial for neuroprotective efficacy of postischaem-
ic hypothermia: the faster cooling is initiated and the faster
target temperature is reached, the better the neuroprotection
[13, 19]. We speculate that the simplicity of passive cooling
may be an important reason why average target temperat-
ures were reached one hour earlier in our study when com-
pared to the NICHD study. Another reason could be that
we did not need to get consent from parents as cooling was
the clinical standard and therefore treatment could be star-
ted earlier. However, it should be noted that most infants
were born elsewhere and required transport to our unit.
In addition, there was a smaller maximum overshoot during
initiation of hypothermia suggesting that temperature con-
trol by nurses may be more reliable than by some high-tech
cooling devices. Another reason for less overshooting may
be the use of counter-warming measures and of pharma-
cological agents to reduce the thermoregulatory stress re-
sponse. Decreased thermal stress response during cooling
may lead to better peripheral vasodilatation with less cent-
ral temperature pooling, and easier cooling initiation and
stabilisation at hypothermic core temperatures, with less
overshooting [7]. Two recent studies in neonates suffering
from perinatal asphyxia have shown minimal overshooting
during induction and maintenance phases of therapeutic
hypothermia by using a new servo-controlled cooling
device: mean maximal overshoot was only 0.3 °C [20–21].
However, neither study documented the consequences of
the new cooling algorithm on induction time, where time
to reach target temperature might become prolonged and
may therefore theoretically impede neuroprotective effect-
iveness [13, 19].
We also tried to compare the severity of the perinatal hyp-
oxic insults between our and the cooled NICHD study pa-
tients, since cooling effectiveness may depend upon sever-
ity of ischaemic insult. Precooling characteristics appear
to be very similar except for the proportion of outborns,
which was higher in our cohort and may have been associ-
ated with a more severe illness. Postcooling characteristics
were also similar, except for a higher percentage of vaso-
active drug use in our study. Theoretically, the latter may be
due to the higher percentage of infants born elsewhere or
due to the lower target temperature in our study. However,
it may also be considered to be an adverse event secondary
to the cooling method and the adjunct therapies used such
as sedation and analgesia.
There are several limitations of the retrospective data col-
lection and analysis. The start of cooling was difficult to
estimate retrospectively. In addition, frequency of temper-
ature recording was not standardised in detail between the
participating centres, but was at least hourly. Therefore, in-
duction time and amount of overshooting might have been
underestimated when compared with the NICHD study, in
which temperature was recorded every 15 minutes for 4
hours, then hourly for 8 hours and thereafter every 4 hours.
We estimate that the risk of underestimation is low since in






Use of cardiovascular drugs 16 (89%) 42 (42%) p <0.001
Platelet transfusion 1 (6%) 20 (20%) p = 0.19
Fresh frozen transfusion 9 (50%) Not reported
Volume expanders 14 (78%) 55 (54%) p = 0.073
Nitric oxide inhalation 2 (11%) 17 (17%) p = 0.74
Seizures at 24 hours 5 (28%) 19 (20) p = 0.74
Cardiac arrhythmia 1 (6%) 1 (1%) p = 0.28
Hypoglycaemia+ 0 12 (12%) p = 0.21
Hepatic dysfunction& 7 (39%) 20 (20%) p = 0.12
Coagulopathy* 3 (16%) 18 (18%) p = 1.00
Persistent metabolic acidosis++ 1 (6%) 1 (1%) p = 0.28
Proven blood stream infection 0 5 (5%) p = 1.00
Death during hospital course 6 (33%) 19 (19%) p = 0.21
1 Missing data for persistent acidosis in the “passive hypothermia” group; +glucose concentration <1.7 mmol/l; &aspartate aminotransferase >200 IU/I and alanine
aminotransferase >100 IU/l, *2 out of 3 pathological values: prothrombin time, activated partial thromboplastin time or fibrinogen; ++pH <7.15 for more than 3 h after
initiation of intervention
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all intensive care units measured physiological values out
of target were routinely recorded.
In conclusion, our preliminary study suggests that passive
cooling is feasible and effective to achieve and maintain
target temperatures in therapeutic hypothermia in asphyxi-
ated newborn infants. In addition, it appears to be associ-
ated with a lower risk of overshooting. These data support
the continuation of this multicentre standard treatment pro-
tocol and the further investigation of the clinical feasibility
and safety of passive hypothermia in asphyxiated neonates.
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Figures (large format)
Figure 1
Mean rectal temperature (± SD) of the cohort during induction and maintenance of passive cooling and during rewarming.
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